another new "glitazone" for type 2 diabetes, Actos (pioglitazone)

You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone)...co-marketed by Lilly and Takeda.

This is the third one...after Avandia (rosiglitazone) and Rezulin (troglitazone).

All three lower blood glucose by improving insulin sensitivity.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote